SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-265192
Filing Date
2018-09-04
Accepted
2018-08-31 19:43:04
Documents
3
Period of Report
2018-08-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d614167d8k.htm 8-K 17879
2 EX-99.1 d614167dex991.htm EX-99.1 6767
3 GRAPHIC g614167g74o51.jpg GRAPHIC 2426
  Complete submission text file 0001193125-18-265192.txt   29358
Mailing Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476
Business Address 3850 ANNAPOLIS LANE NORTH, SUITE 180 PLYMOUTH MN 55447-5476 612-747-4423
BioAmber Inc. (Filer) CIK: 0001534287 (see all company filings)

IRS No.: 980601045 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35905 | Film No.: 181050956
SIC: 2860 Industrial Organic Chemicals